Ian Collins
- Oncology top 10%
- Genetics top 10%
- Public Health, Environmental and Occupational Health top 10%
- Reproductive Medicine top 5%
- General Health Professions
- Co-authors
- Kelly‐Anne PhillipsJohn L. HopperMichael FriedländerRoger L. MilnePrue C. WeidemanR B ClaguePhyllis ButowK Morgan
- Topics
- BRCA gene mutations in cancer (12 papers)Global Cancer Incidence and Screening (12 papers)HER2/EGFR in Cancer Research (9 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Ian Collins
60 papers receiving 619 citations
Peers
Comparison fields: 5 of 102
- Oncology 239
- Genetics 203
- Public Health, Environmental and Occupational Health 168
- Reproductive Medicine 133
- General Health Professions 68
Countries citing papers authored by Ian Collins
This map shows the geographic impact of Ian Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Collins more than expected).
Fields of papers citing papers by Ian Collins
This network shows the impact of papers produced by Ian Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Collins. The network helps show where Ian Collins may publish in the future.
Co-authorship network of co-authors of Ian Collins
This figure shows the co-authorship network connecting the top 25 collaborators of Ian Collins. A scholar is included among the top collaborators of Ian Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Collins. Ian Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 4 | |
| 8 | 13 | |
| 9 | 8 | |
| 10 | 26 | |
| 11 | 22 | |
| 12 | 41 | |
| 13 | 20 | |
| 14 | 43 | |
| 15 | 3 | |
| 16 | 11 | |
| 17 | 12 | |
| 18 | 24 | |
| 19 | 6 | |
| 20 | 5 |
About Ian Collins
Ian Collins is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 65 papers that have together received 638 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (12 papers), Global Cancer Incidence and Screening (12 papers) and HER2/EGFR in Cancer Research (9 papers). The work is most often cited by research in Reproductive Medicine (133 citations), Oncology (239 citations) and Genetics (203 citations). Ian Collins has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Kelly‐Anne Phillips, John L. Hopper, Michael Friedländer, Roger L. Milne, Prue C. Weideman, R B Clague, Phyllis Butow, K Morgan, P.J. Holt and Sabry Ayad. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.